A tight control of BP with pharmacological therapy like ARBs, ACE inhibitors, or β-blockers, diuretics, and calcium channel blockers helps in minimizing CVD risks in patients with T2DM [2]. This evidence concerns the gene ACE and type 2 diabetes mellitus.